Skip to content
Bored Studies
RecruitingAccepts healthy volunteersEarly Phase 1

Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia

Anna Stanhewicz, PhD · NCT05937841

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–45 · Women only
Healthy volunteers
Accepted
Study type
Interventional · Early Phase 1
Target enrollment
30
US sites recruiting
1
Study start
June 28, 2023
Record last updated
August 24, 2025

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Women who develop preeclampsia during pregnancy are more likely to develop and die of cardiovascular disease later in life, even if they are otherwise healthy. The reason why this occurs is unclear but may be related to impaired endothelial function and dysregulation of the angiotensin system that occurs during the preeclamptic pregnancy and persists postpartum, despite the remission of clinical symptoms. The purpose of this investigation is to determine the mechanisms contributing to this lasting blood vessel damage caused by reduced endothelial function in women who have had preeclampsia compared to women who had a healthy pregnancy. Identification of these mechanisms and treatment strategies may lead to better clinical management of cardiovascular disease risk in these women.

The purpose of this study is to examine the microvascular differences in women who have had preeclampsia following activation of protective angiotensin receptors in the skin. This will help increase understanding of the mechanisms of angiotensin II receptors in these women, and how activation of these receptors may restore microvascular function.

In this study, the investigators use the blood vessels in the skin as a representative vascular bed for examining mechanisms of microvascular dysfunction in humans. Using a minimally invasive technique (intradermal microdialysis for the local delivery of pharmaceutical agents) the investigators examine the blood vessels in a dime-sized area of the skin.

Being studied: Compound 21

Conditions: Preeclampsia Postpartum

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • women who had preeclampsia and women who did not have preeclampsia
  • 12 weeks to 5 years postpartum
  • 18-45 years old

Exclusion Criteria

  • history of hypertension or metabolic disease before pregnancy
  • history of gestational diabetes
  • skin diseases
  • current tobacco use
  • current antihypertensive medication
  • statin or other cholesterol-lowering medication
  • currently pregnant or planning to become pregnant
  • body mass index less than 18.5 kg/m2
  • allergy to materials used during the experiment.(e.g. latex),
  • known allergy to study drugs

Recruiting US locations

  • University of Iowa

    Iowa City, IA 52242

    Site contact: Kelsey Schwartz · 319-467-3096 · kelsey-schwartz@uiowa.edu

Study contacts (from the official record)

  • Kelsey Schwartz · 319-467-3096 · kelsey-schwartz@uiowa.edu
All pregnancy studies in Iowa →
Sensitivity of Angiotensin II Type II Receptors in Women Following… (NCT05937841) | Bored Studies